Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

Akero Therapeutics, Inc. (AKRO) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $25.22 Metrics
OS: 28.7 M -42 % ROE
Market cap: $723 M -72 % ROIC
Net cash: $236 M $8.23 per share
EV: $487 M

 
TTM Valuation
EBITDA ($52.5) M
EBIT ($52.5) M
EPS ($4.22)

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-19Dec-31-18
Revenues0.00.0
Cost of goods sold0.00.0
Gross profit0.00.0
Research and development37.011.9
General and administrative8.61.9
EBIT-45.7-13.8
Pre-tax income-43.7-81.7
Income taxes0.00.0
            Tax rate 0.0%
Net income-43.8-82.2
 
Diluted EPS($2.90)($795.28)
Shares outstanding (diluted)15.10.1
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy